These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 11958686)

  • 1. Recovery of replication-competent HIV type 1-infected circulating monocytes from individuals receiving antiretroviral therapy.
    Harrold SM; Wang G; McMahon DK; Riddler SA; Mellors JW; Becker JT; Caldararo R; Reinhart TA; Achim CL; Wiley CA
    AIDS Res Hum Retroviruses; 2002 Apr; 18(6):427-34. PubMed ID: 11958686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-1 can be recovered from a variety of cells including peripheral blood monocytes of patients receiving highly active antiretroviral therapy: a further obstacle to eradication.
    Crowe SM; Sonza S
    J Leukoc Biol; 2000 Sep; 68(3):345-50. PubMed ID: 10985250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased replication of non-syncytium-inducing HIV type 1 isolates in monocyte-derived macrophages is linked to advanced disease in infected children.
    Tuttle DL; Anders CB; Aquino-De Jesus MJ; Poole PP; Lamers SL; Briggs DR; Pomeroy SM; Alexander L; Peden KW; Andiman WA; Sleasman JW; Goodenow MM
    AIDS Res Hum Retroviruses; 2002 Mar; 18(5):353-62. PubMed ID: 11897037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human immunodeficiency virus type 1 in the semen of men receiving highly active antiretroviral therapy.
    Zhang H; Dornadula G; Beumont M; Livornese L; Van Uitert B; Henning K; Pomerantz RJ
    N Engl J Med; 1998 Dec; 339(25):1803-9. PubMed ID: 9854115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of Heme Oxygenase-1 Deficiency and Associated Glutamate-Mediated Neurotoxicity Is a Highly Conserved HIV Phenotype of Chronic Macrophage Infection That Is Resistant to Antiretroviral Therapy.
    Gill AJ; Kovacsics CE; Vance PJ; Collman RG; Kolson DL
    J Virol; 2015 Oct; 89(20):10656-67. PubMed ID: 26269184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced culture method for detection of replication-competent virus in peripheral blood mononuclear cells of HIV type 1-infected individuals.
    Haran JP; Greenough TC; Luzuriaga K; Sullivan JL; Flanigan T; Somasundaran M
    AIDS Res Hum Retroviruses; 2002 May; 18(8):577-83. PubMed ID: 12036487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for human immunodeficiency virus type 1 replication in vivo in CD14(+) monocytes and its potential role as a source of virus in patients on highly active antiretroviral therapy.
    Zhu T; Muthui D; Holte S; Nickle D; Feng F; Brodie S; Hwangbo Y; Mullins JI; Corey L
    J Virol; 2002 Jan; 76(2):707-16. PubMed ID: 11752161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infrequent HIV Infection of Circulating Monocytes during Antiretroviral Therapy.
    Massanella M; Bakeman W; Sithinamsuwan P; Fletcher JLK; Chomchey N; Tipsuk S; Chalermchai T; Routy JP; Ananworanich J; Valcour VG; Chomont N
    J Virol; 2019 Dec; 94(1):. PubMed ID: 31597764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cellular HIV DNA quantitative testing and its significance in Chinese AIDS patients during 48 weeks' highly-active antiretroviral treatment].
    Zheng YH; Alius DM; Chen X; He Y; He B; He M; Wang HY; Xiao SL; Luo Y; Yao YH; Lin YH; Chen Z; Zhou HY
    Zhonghua Nei Ke Za Zhi; 2012 Sep; 51(9):708-12. PubMed ID: 23158922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of infectious HIV in circulating monocytes from patients on prolonged highly active antiretroviral therapy.
    Lambotte O; Taoufik Y; de Goër MG; Wallon C; Goujard C; Delfraissy JF
    J Acquir Immune Defic Syndr; 2000 Feb; 23(2):114-9. PubMed ID: 10737425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistence of HIV-1 transcription in peripheral-blood mononuclear cells in patients receiving potent antiretroviral therapy.
    Furtado MR; Callaway DS; Phair JP; Kunstman KJ; Stanton JL; Macken CA; Perelson AS; Wolinsky SM
    N Engl J Med; 1999 May; 340(21):1614-22. PubMed ID: 10341273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy.
    Zhang L; Ramratnam B; Tenner-Racz K; He Y; Vesanen M; Lewin S; Talal A; Racz P; Perelson AS; Korber BT; Markowitz M; Ho DD
    N Engl J Med; 1999 May; 340(21):1605-13. PubMed ID: 10341272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significant reduction in HIV-1 plasma viral load but not in proviral infected cells during sub-optimal antiretroviral therapy.
    Riva E; Antonelli G; Solmone MC; Turriziani O; Narciso P; Tozzi V; Dianzani F
    J Biol Regul Homeost Agents; 2000; 14(1):1-3. PubMed ID: 10763882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ex-vivo purging of circulating monocytes results in immunovirologic improvement in partially HAART responder HIV-infected patients.
    Beretta A; Clerici M; Hasson H; Fumagalli L; Trabattoni D; Lillo F; Ferrante P; Saniabadi AR; Adachi M; Lazzarin A
    J Biol Regul Homeost Agents; 2000; 14(1):27-31. PubMed ID: 10763888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV production from purified monocytes isolated from antiretroviral-naïve and protease inhibitor-treated HIV-1-infected patients.
    Kazanjian P; Adams D; Tate S; Newman G
    HIV Clin Trials; 2002; 3(6):469-74. PubMed ID: 12501130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of influenza vaccination on viral replication and immune response in persons infected with human immunodeficiency virus receiving potent antiretroviral therapy.
    Günthard HF; Wong JK; Spina CA; Ignacio C; Kwok S; Christopherson C; Hwang J; Haubrich R; Havlir D; Richman DD
    J Infect Dis; 2000 Feb; 181(2):522-31. PubMed ID: 10669335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Consensus document of Gesida and Spanish Secretariat for the National Plan on AIDS (SPNS) regarding combined antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2012)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2012 Jun; 30(6):e1-89. PubMed ID: 22633764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation of human immunodeficiency virus type 1 from peripheral blood monocytes.
    Gorry PR; Sonza S; Kedzierska K; Crowe SM
    Methods Mol Biol; 2005; 304():25-33. PubMed ID: 16061964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased recovery of replication-competent HIV-1 from peripheral blood mononuclear cell-derived monocyte/macrophages of HIV-positive patients after 3 years on highly active antiretroviral therapy.
    Belmonte L; Baré P; Picchio GR; Perez Bianco R; de Tezanos Pinto M; Corti M; Villafañe MF; de Bracco MM; Ruibal-Ares BH
    AIDS; 2002 Jun; 16(9):1289-92. PubMed ID: 12045497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-1-specific immune responses in subjects who temporarily contain virus replication after discontinuation of highly active antiretroviral therapy.
    Ortiz GM; Nixon DF; Trkola A; Binley J; Jin X; Bonhoeffer S; Kuebler PJ; Donahoe SM; Demoitie MA; Kakimoto WM; Ketas T; Clas B; Heymann JJ; Zhang L; Cao Y; Hurley A; Moore JP; Ho DD; Markowitz M
    J Clin Invest; 1999 Sep; 104(6):R13-8. PubMed ID: 10491418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.